06.04.21
Prohibition Partners
Who are SOMAÍ Pharmaceuticals?
SOMAÍ Pharmaceuticals is an international company focused on creating unique cannabis formulations for the EU market, developed and manufactured inline with EU GMP regulations for pharmaceutical products.
01.04.21
MedPage Today
On the heels of the cannabidiol (CBD) craze come three other cannabinoids touted as potential treatments for various medical issues
01.04.21
Cannabis Business Executive
Good Manufacturing Practices, or GMP, are a systematic way of ensuring that products — from food to supplements to pharmaceuticals — are produced consistently according to established quality control standards. Essentially, GMP ensures a universal minimum standard of quality to protect consumers.
26.03.21
Benzinga
When the COVID-19 pandemic hit the world by surprise last year, cannabis businesses around the world faced the uncertainty of one of the most challenging years for everyone.
26.03.21
Yahoo Finance
When the COVID-19 pandemic hit the world by surprise last year, cannabis businesses around the world faced the uncertainty of one of the most challenging years for everyone.
25.03.21
Fanack
Morocco approved in March 2021 a law that will see a legal cannabis industry emerge in one of the highest marijuana producing countries in the world. The move could bring significant benefits to Morocco but challenges remain for farmers who make most of their income from the resin that will linger in the informal and illegal economy.
22.03.21
Benzinga
SOMAÍ Pharmaceuticals Ltd. co-founder and CEO Michael Sassano recently spoke to Benzinga about a particular value buy that’s piqued his interest.
He also touched on recent market fluctuations, the global marketplace’s development and what it means to investors.
22.03.21
Cannabis Industry Journal
The unusual nature of 2020 gave rise to a reciprocally roller-coaster-like cannabis market. Cannabis was cemented officially as an essential industry with the rise of COVID-19, and November elections resulted in even more United States markets welcoming medical and adult-use sales.
22.03.21
Cannabis Business Executive
If you’re reading this you undoubtedly know that special purpose acquisition companies (SPACs) are all the rage. So, let’s talk about the future of raising money in cannabis.